Artificial Organs and Bionics Market
According to Intent Market Research, the Artificial Organs and Bionics Market is expected to grow from USD 22.7 billion in 2023 at a CAGR of 14.1% to touch USD 57.2 billion by 2030. The Artificial Organs and Bionics Market is dominated by key players such as Medtronic plc, Boston Scientific Corporation, Siemens Healthineers, Cochlear Limited, Otto Bock Healthcare GmbH, Abbott Laboratories, Blackrock Microsystems LLC, Biotronik SE & Co. KG, Ekso Bionics Holdings, Inc., TMS International, LifeNet Health, Hanger, Inc. and Cigna Corporation.